LVRS does not accelerate rate of decline in FEV1

D. Testelmans, T. Troosters, G. Verleden, D. Van Raemdonck, M. Decramer (Leuven, Belgium)

Source: Annual Congress 2003 - Surgery for chest neoplasms and VATS
Session: Surgery for chest neoplasms and VATS
Session type: Poster Discussion
Number: 2329

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Testelmans, T. Troosters, G. Verleden, D. Van Raemdonck, M. Decramer (Leuven, Belgium). LVRS does not accelerate rate of decline in FEV1. Eur Respir J 2003; 22: Suppl. 45, 2329

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017


Re-assessing the importance of FEV1 decline
Source: Eur Respir Monogr 2015; 69: 134-142
Year: 2015


Frequent exacerbations in COPD are associated with accelerated rate of FEV1 decline
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

Prediction of all cause mortality in a population sample is improved by using FEV1 quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


1 year RV/TLC change as a predictor of long term decline of FEV1
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

The correlation of annual rate of FEV1 decline with the temperature of expired air in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Individual decline of FEV1 show diversity in COPD
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012


Midflows do not vary independently of FEV1 and FVC
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011

Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR®
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003

Early health status improvements decline after LVRS despite persistent reduction in lung volume
Source: Eur Respir J 2002; 20: Suppl. 38, 607s
Year: 2002

Association between weight loss and decline in FVC in patients with IPF
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database
Source: Annual Congress 2011 - Lung and airway function
Year: 2011


Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016


The evaluation of different factors that cause FEV1 decline in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001

Frequent exacerbations in ex smokers with COPD are associated with accelerated rate of FEV1 decline
Source: Eur Respir J 2005; 26: Suppl. 49, 510s
Year: 2005

Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up
Source: Eur Respir J 2016; 47: 742-750
Year: 2016



The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002